The anaphylatoxin C3a triggers inflammation by binding to its specific G-protein-coupled C3a receptor (C3aR). Since the number of C3aR, which is expressed on the cell surface, affects the response to C3a, we investigated the expression levels of C3aR on human M2 macrophages in allergic situations where high levels of the Th2 cytokine IL-4 and histamine are present in a local microenvironment. The histamine H1 receptor (H1R), H2R and the H4R mRNA expressions were induced or up-regulated during the differentiation process of M2 macrophages. The presence of histamine or agonists targeting the H1R, H2R and, in particular, the H4R during in vitro differentiation from monocytes to macrophages modified the M2 phenotype by regulating the macrophage differentiation marker CD68 and CD163 expressions. In addition, the C3aR expression was also down-regulated by ST-1006 during this process. Histamine and ST-1006 down-regulated the expression of C3aR with different time kinetics on fully differentiated M2 macrophages. By analysing C3a-induced IL-6 mRNA expression, we observed a diminished response to C3a in ST-1006-treated M2 macrophages when compared to un-treated cells. Expression of C3 was not affected by histamine, whereas IL-4 strongly down-regulated C3aR and C3 expressions. Our data suggests that down-regulation of C3aR expression by mediators present in allergic situations such as IL-4 or histamine has an anti-inflammatory impact by reducing the sensitivity to C3a-induced down-stream signaling, thereby contributing to the regulation of local inflammatory responses in the skin.
Introduction
Monocytes and macrophages are potent effectors bridging the innate and adaptive immune system by killing pathogens by phagocytosis and by producing inflammatory mediators in response to activating signals in their microenvironment. They also contribute to the resolution of inflammation by homeostatic clearance of cellular debris, thereby promoting tissue repair and remodelling. Monocyte-derived macrophages occupy within tissues a specific niche and differ in function depending on the local cytokine-chemokine milieu [1] [2] [3] . In lesional DOI: 10.1159/000490426 skin of patients with atopic dermatitis (AD), macrophages reside in the dermal mononuclear cell infiltrate. AD is one of the most frequent chronic inflammatory skin diseases, typically directed by an impaired skin barrier function and modifications of the immune system [4, 5] . At the early onset of AD, IL-4 and IL-13 represent the dominating cytokines, which in turn drive the polarization of macrophages into the M2a phenotype [6, 7] . Almost 4 decades ago, it was observed that the intensities of changes of complement and histamine levels in 15 patients with AD correlated with disease severity [8] . Moreover, intradermal injections of the anaphylatoxin C3a in human skin induced a dose-dependent wheal and flare reaction similar to the appearance of the classical response to histamine [9] [10] [11] . Since the anaphylatoxin fragments C3a and C5a induce chemotaxis as well as mediator release from basophils and mast cells, this effect could be attributed to the impact of histamine [10] [11] [12] . These events point to a potential crosstalk between complement factors and histamine in the course of allergic diseases. The complement system is an ancient major defence system whose activation occurs in a cascade-like fashion upon stimulation of pathogens or other danger signals. The pathway-specific activation (classical, lectin or alternative) of the third component C3 leads to the formation of C3 convertase, which cleaves C3 into the effector molecules C3a and C3b, which drive the microbial clearance [13] . The C3a receptor (C3aR), a G-protein-coupled receptor, specifically binds the anaphylatoxin fragment C3a. The C3aR is functionally expressed on human keratinocytes [14] , and on immune cells constituting the dermal infiltrate in AD skin, such as monocytes [15] , dendritic cells (DCs) [16, 17] or activated T lymphocytes [18] . For this reason, the complement system seems to play a role in the pathogenesis of AD. Histamine is a mediator of allergic reactions and is present in the skin of AD [19] . Important immunoregulatory effects exerted by histamine targeting 4 distinct histamine receptors (HR), which are differentially expressed on immune cells, had been described so far [20] [21] [22] . Macrophages as prominent innate immune cells express high amounts of C3aR on their cell surface [23] and also the histamine-H1-, H2-and H4 receptor mRNA [24] . We observed an induction or upregulation of H1R, H2R and H4R mRNA expressions by trend during the process of differentiation from monocytes to M2 macrophages. An influence of the Th2 cytokine IL-4, which is overexpressed in the acute phase of AD on the regulation of C3aR or C3 expression, has not been described until now for human M2 macrophages. Therefore, we investigated whether IL-4 regulates C3aR and C3 expressions on fully differentiated M2 macrophages. Moreover, we investigated a functional role of histamine, in particular via H4R, on C3aR expression in human monocyte derived M2 macrophages when histamine or the H4R agonist ST-1006 was supplemented to the medium during in vitro differentiation of monocytes to M2 macrophages. Finally, we stimulated fully differentiated M2 macrophages with histamine or different HR agonists targeting the H1R, H2R or H4R and analysed C3aR and C3 expression levels.
Materials and Methods

Isolation of Monocyte Derived Macrophages
Residual blood samples from platelet apheresis disposables used for routine platelet collection and of regular anonymous healthy donors (buffy coats) served as source material for the isolation of human peripheral blood mononuclear cells (PBMCs). PBMCs were separated by density gradient centrifugation on lymphoprep (Fresenius Kabi Norge AS, Oslo, Norway). With a seeding density of 1 × 10 6 cells pro well, PBMCs were plated in a 24 well plate in Iscoves Medium supplemented with AB serum (2.5% v/v). To attach the monocytes, cells were incubated for 2h at 5% CO 2 and 37 ° C. Non adherent cells were removed by vigorously washing adherent cells 3 times with PBS. An appropriate amount of RPMI 1640, supplemented with 2 mM L-glutamine, 100 mg/mL penicillin/streptomycin, 12 mM Hepes, and 5% v/v FCS (PAN-Biotech, Aidenbach, Germany; all other media components from Biochrom, Berlin, Germany) and 10 ng/mL macrophage colony-stimulating factor (M-CSF; R&D, San Diego, CA, USA) was added.
Cell Culture, Differentiation of M2 Macrophages
Cells were differentiated to M2 macrophages under different experimental settings:
1. Cells were cultured with M-CSF during the differentiation process to M2 macrophages.
2. Cells were cultured with M-CSF and in the presence of histamine or different HR agonists targeting the H1R, H2R or H4R during the differentiation process to M2 macrophages.
At day 5, another 50% by volume of fresh medium containing the respective stimuli was added. At day 8, the medium was completely changed. The differentiation process was controlled by analysing the expression levels of macrophage differentiation marker CD68 and the M2 marker CD163 at day 1, 3, and 7 on cells which were cultured with M-CSF only. At day 10, CD68 and CD163 expression levels were assessed on all cells in the different experimental settings. C3aR was measured on macrophages, which were differentiated with M-CSF only compared to histamine or ST-1006-treated cells. 
Stimulation of Fully
Histamine Receptor Ligands
The following histamine receptor ligands were used in this study: Histamine (or respective vehicle control; ALK-Abello, Madrid, Spain) as agonist for all HR; 2-pyridylethylamine (Tocris Bioscience, Bristol, UK) as selective H1R agonist; amthamine (Tocris Bioscience, Bristol, UK) as selective H2R agonist; ST-1006 (Institute of Pharmaceutical and Medicinal Chemistry, Heinrich Heine University, Duesseldorf, Germany) as H4R agonist [25] ; JNJ39758979 (Sigma Aldrich, Deisenhofen, Germany) as selective H4R antagonist; Mercaptoethanol (Sigma Aldrich, Deisenhofen, Germany) as vehicle control. All histamine receptor ligands were used at a concentration of 10 µM. In extensive previous studies, we could show that the concentration of 10 µM is optimal to demonstrate and reproduce robust H4R agonist mediated effects [26] .
Real-Time Quantitative LightCycler RT-PCR
Total RNA was isolated using the RNeasy kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions. The cDNA was synthesized by reverse transcription (QuantiTect reverse transcription kit, Qiagen, Germany). Real-time quantitative PCR was performed according to the MIQE guidelines with Quantitect ® primer assays for C3aR (QT00090398), C3 (QT00089698), IL-6 (QT00083720), H1R (QT00199857), H2R (QT00210378), H3R (QT00210861), H4R (QT00032326) and rps 20 (ribosomal protein S20) (QT00079247) using SYBR ® Green according to the manufacturer's instructions (Qiagen, Hilden, Germany) using the LightCycler 480. The amount of the target mRNA relative to the amount of the reference gene, ribosomal protein S20 (rps 20), mRNA in the same sample was calculated using the comparative Ct method also known as the [ delta] [delta] Ct method provided by the Software LC 480 (Roche Molecular Biochemicals). The Ct values of both the calibrator and the samples of interest are normalized to the appropriate endogenous reference gene rps 20.
Flow Cytometric Analysis of CD68 and CD163
Monocyte-derived M2 macrophages after day 1, 3 and 7, nonstimulated macrophages and macrophages treated with histamine or different HR agonists targeting the H1R, H2R, or the H4R during the whole differentiation process were carefully scraped from the culture plates and seeded (5 × 10 5 cells per well) into 96 well plates. Fc receptors were blocked by incubation in a buffer containing 10 µg/mL heat-aggravated human immunoglobulin G (IgG; Sigma, Deisenhofen, Germany). An extracellular epitope of CD163 was stained with anti-human CD163-PE (mouse monoclonal IgG1, 1 µg/100 µL; BioLegend, San Diego, CA, USA), the respective isotype control IgG1 was tested in parallel. Cells were fixed, permeabilized using the BD Cytofix/Cytoperm fixation/permeabilization kit (BD Bioscience) and CD68, which is intracellularly expressed in cytoplasmic granules and was stained with anti-human CD68-APC (mouse monoclonal IgG2b, 0,125 µg/100 µL; BioLegend); the respective isotype control IgG2b was tested in parallel. Sample acquisition was performed by flow cytometry (FACS Calibur, Becton Dickinson, Heidelberg, Germany) and mean fluorescence intensities (MFI) were calculated using the CellQuest Pro software (Becton Dickinson). To assess cell viability, macrophages were incubated with Annexin V-FITC and Propidium iodide for 15 min (BD Bioscience) and analysed by flow cytometry (FACS Calibur, Becton Dickinson).
Flow Cytometric Analysis of C3aR
Fully differentiated M2 macrophages and macrophages treated with histamine or ST-1006 during the whole differentiation process were carefully scraped from the culture plates and seeded (5 × 10 5 cells per well) into 96 well plates. Fc receptors were blocked by incubation in a buffer containing 10 µg/mL heat-aggravated human IgG (Sigma, Deisenhofen, Germany). A specific epitope of C3aR was stained with anti-human C3aR-APC (mouse monoclonal IgG2b, 1 µg/100 µL; BioLegend, San Diego, CA, USA), the respective isotype control IgG2b was tested in parallel. Sample acquisition was performed by flow cytometry (FACS Calibur [ Fig. 1 The MFI values of the isotype controls of non-stimulated or of stimulated cells were in the same range. Histamine or specific his- 
Statistics
For statistical analyses, the software GraphPad Prism Version 5.0 was used (GraphPad software, San Diego, CA, USA). Wilcoxon matched pairs test or Repeated Measures by ANOVA, Dunnett's Multiple Comparison test was performed and the median or mean is shown in the graph. A p value < 0.05 was regarded as statistically significant (p < 0.05 was labelled with * p < 0.01 was labelled with ** p < 0.001 was labelled with ***).
Ethics
The investigation of the role of the HR in inflammatory diseases was approved by the local Ethics Committee of the Hannover Medical School (Vote 4253) and was conducted according to the Declaration of Helsinki Principles.
Results
The H1R, H2R and the H4R mRNA Expressions Are Induced or Up-Regulated by Trend during the Differentiation Process of M2 Macrophages. The Expression Levels of the Macrophage Differentiation Marker CD68 and the Scavenger Receptor CD163 Are Differentially Regulated in the Presence of Histamine or Histamine Receptor Agonists during the Differentiation Process of M2 Macrophages
In vitro differentiation of monocytes (day 0) in the presence of M-CSF led to the generation of M2 macrophages (day 10) by up-regulating or inducing the expression of the H1R, H2R and the H4R mRNA by trend (Fig. 1b-d) . The differentiation marker CD68 and the characteristic M2 macrophage marker CD163 were upregulated during the differentiation process and ex- pressed at high levels at day 7 when compared to the expression levels at day 1 or day 3 of the differentiation process (Fig. 1e, j) . We differentiated monocytes to M2 macrophages with M-CSF and in the presence of M-CSF supplemented with histamine, 2-pyridylethylamine (H1R agonist), amthamine (H2R agonist) and with ST-1006. Expression levels of CD68 and CD163 were measured by flow cytometry. We observed that the expression of CD68 was up-regulated on fully differentiated M2 macrophages treated by histamine, 2-pyridylethylamine and ST-1006. Amthamine did not regulate CD68 expression (Fig. 1f-i) . In contrast, the expression of CD163 was significantly up-regulated by amthamine stimulation. Stimulation via H4R down-regulated CD163 expression. Histamine and the H1R agonist 2-pyridylethylamine had no effect on CD163 expression (Fig. 1k-n) . The cell viability of M2 macrophages showed no remarkable deviations between cells treated with histamine (data not shown) or ST-1006 during the period of differentiation as assessed by Propidium Iodide and Annexin V-FITC staining when compared to un-treated cells (online suppl. Fig. 1, see www. karger.com/ doi/10.1159/000490426).
The mRNA and Surface Expression Levels of C3aR Are Down-Regulated in the Presence of the H4R Agonist ST-1006 during the Differentiation Process of M2 Macrophages
We examined the influence of histamine, in particular via H4R, on C3aR expression levels during the differentiation process from monocytes to macrophages. We differentiated monocytes to M2 macrophages: (i) with M-CSF, (ii) with M-CSF and in the presence of histamine, (iii) with M-CSF and in the presence of ST-1006. Expression levels of C3aR were measured by quantitative PCR and by flow cytometry. We observed that the mRNA and surface expressions of C3aR were significantly down-regulated of 62% and of 74%, respectively, on macrophages treated with M-CSF and ST-1006 during the differentiation period when compared to macrophages supplemented with M-CSF only (Fig. 2b-d) . Histamine had no consistent effects at the expression levels of C3aR when the substance is presented during the whole differentiation process. This may be due to the long incubation period of histamine or due to opposite effects at other HR.
C3aR mRNA Expression is Down-Regulated upon Stimulation with the H4R Agonist ST-1006 after 24 h and by Trend with Histamine after 6 h in Fully Differentiated M2 Macrophages
Next, we studied the influence of histamine or ST-1006 on fully differentiated human M2 macrophages. Fully differentiated human M2 macrophages were stimulated with histamine or ST-1006 for different periods of time. C3aR expression was analysed by quantitative PCR. We observed down-regulation of C3aR mRNA expression upon histamine stimulation after 6 h by trend and a time- dependent down-regulation of C3aR mRNA expression upon stimulation with ST-1006 of 57% after 24 h (Fig. 3b,  c) . Stimulation with 2-pyridylethylamine (H1R agonist) or amthamine (H2R agonist) for 24 h did not regulate C3aR mRNA expression levels when compared to untreated samples (Fig. 3d) . C3 mRNA expression levels were not regulated by histamine, 2-pyridylethylamine (H1R agonist), amthamine (H2R agonist) or ST-1006 (H4R agonist) after a stimulation period of 6 h or 24 h (Fig. 3e, f) .
Histamine or the H4R Agonist ST-1006 Differentially Down-Regulates the C3aR Surface Expression on Fully Differentiated M2 Macrophages
Fully differentiated M2 macrophages were stimulated for different time periods with histamine or ST-1006. Analysing the expression of C3aR by flow cytometry on M2 macrophages, we detected a significant down-regulation of C3aR surface expression by ST-1006 over time, which was most pronounced after 3, 5 and 7 days (Fig. 4b) , whereas histamine had less effects at these late time points (data not shown). To rule out if this effect is specific for the H4R, we blocked the receptor 30 min before stimulation. For blocking the H4R we used the H4R antagonist JNJ 39758979, which has been shown to be effective in reducing histamine-induced pruritus in a clinical study in healthy subjects [27] . As shown in Figure 4c , in the presence of the selective H4R antagonist JNJ 39758979, the down-regulation of C3aR surface expression was partly reversed, confirming a functional role of the H4R for this effect.
To investigate if the down-regulation of C3aR is regulated also by other HR, we stimulated the M2 macrophages besides ST-1006 with histamine, 2-pyridylethylamine (H1R agonist) and with amthamine (H2R agonist) for 3 days. As shown in Figure 4d , we revealed a slight downregulation of C3aR by trend with histamine. We assumed that different time kinetics in the histamine-or histamine receptor-specific agonist-mediated pathways exist. Therefore, we stimulated M2 macrophages with histamine, 2-pyridylethylamine (H1R agonist), amthamine (H2R ag- onist) or with ST-1006, instead of 3 days, for a shorter time period of 16-18 h. Analysing C3aR surface expression, we observed that ST-1006 as well as histamine down-regulated C3aR expression after 16-18 h when compared to nonstimulated samples (Fig. 4e) . The H1R and H2R agonists were less effective.
The Down-Regulation of C3aR via H4R Is of Functional Relevance. ST-1006-Treated M2 Macrophages Express Lower Levels of C3aR mRNA. Stimulation with C3a Results in Lower Amounts of IL-6 mRNA Expression in ST-1006-Treated when Compared to Un-Treated Cells
Fully differentiated human M2 macrophages were treated with ST-1006 for 24 h or were left un-treated. The cells in the ST-1006-treated group showed a down-regulation of C3aR mRNA expression (Fig. 5b) . After 24 h, both groups were stimulated with C3a (1 ng/mL) for further 24 h. M2 macrophages, which were stimulated with C3a, only showed a more than 4 fold up-regulation of IL-6 mRNA expression when compared to the cells where the C3aR had been down-regulated by ST-1006 before. Stimulation of the cells with ST-1006 only for 24 h had no effect at the IL-6 mRNA expression (Fig. 5c) .
IL-4 Down-Regulates C3aR mRNA and Surface Expressions on Fully Differentiated Human M2 Macrophages
Fully differentiated human M2 macrophages were stimulated with IL-4 (20 ng/mL) for different time periods. C3aR expression was analysed by RT-PCR. We observed a stepwise down-regulation of C3aR mRNA expression by time (Fig. 6b) . We performed some additional experiments using the optimal time period of 24 h for IL-4 stimulation and found that C3aR mRNA was significantly down-regulated of 75% (Fig. 6c) . The expression of C3aR on the cell surface was analysed by flow cytometry. Here, we observed a significant down-regulation of C3aR expression by IL-4 after 48 h (data not 
